Publications and Articles

PUBLICATIONS

Belgian guidance 2026 on management of pregnancy and breastfeeding in women living with HIV and their infants.
Konopnicki D, Hainaut M, Adler C, De Greef J, Belkhir L, Laurent F, Van Praet J, Nagel J, Caluwaerts S, Schmitz V, Vander Linden D, Chatzis O, Stoffels K, Pelgrom J, Barlow P; Belgium Research on AIDS and HIV Consortium; (BREACH) working group.Eur J Obstet Gynecol Reprod Biol. 2026 Jul 13;325:115312. doi: 10.1016/j.ejogrb.2026.115312.
A Characterization of Women Living with HIV in Belgium.
Nasreddine R, Yombi JC, Darcis G, Van Frankenhuijsen M, Van Petersen L, Abels C, Dos Santos Mendes S, Delforge M, De Wit S.
AIDS Res Treat. 2024 Sep 26;2024:5590523. doi: 10.1155/2024/5590523. eCollection 2024.
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Florence E, Yombi JC, Henrard S, Darcis G, Van Praet J, Vandekerckhove L, Allard SD, Demeester R, Messiaen P, Ausselet N, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH).
HIV Med. 2023 Aug;24(8):914-924. doi: 10.1111/hiv.13493. Epub 2023 Apr 10.
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Yombi JC, Darcis G, Florence E, Allard SD, De Scheerder MA, Henrard S, Demeester R, Messiaen P, Ausselet N, Loeckx M, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH).HIV Med. 2023 Mar;24(3):267-278. doi: 10.1111/hiv.13373. Epub 2022 Aug 8.
A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study.
Nasreddine R, Darcis G, Yombi JC, De Munter P, Florence E, Van Praet J, Demeester R, Allard SD, Schroeder M, Dusabineza AC, Delforge M, De Wit S.Acta Clin Belg. 2024 Jun;79(3):153-159. doi: 10.1080/17843286.2024.2359184. Epub 2024 May 30.
Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
Nasreddine R, Florence E, Moutschen M, Yombi JC, Goffard JC, Derdelinckx I, Lacor P, Vandekerckhove L, Messiaen P, Vandecasteele S, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH).J Med Virol. 2021 May;93(5):2971-2978. doi: 10.1002/jmv.26828. Epub 2021 Feb 9.PMID: 33506953 Free PMC article.
Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.
Nasreddine R, Florence E, Vandercam B, Moutschen M, Goffard JC, De Munter P, Delforge M, Marinus W, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH).AIDS. 2020 Jul 1;34(8):1151-1159. doi: 10.1097/QAD.0000000000002533.PMID: 32287063
Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort.
Van Beckhoven D, Florence E, De Wit S, Wyndham-Thomas C, Sasse A, Van Oyen H, Macq J; Belgian Research on AIDS, HIV Consortium (BREACH).HIV Med. 2020 Oct;21(9):557-566. doi: 10.1111/hiv.12901. Epub 2020 Jul 5.
Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients.
De Wit S, Florence E, Vandekerckhove L, Vandercam B, Goffard JC, Van Wijngaerden E, Moutschen M, Demeester R, Thilakarathne P, Piryns H; BREACH* Consortium.
Acta Clin Belg. 2018 Oct;73(5):341-347. doi: 10.1080/17843286.2018.1458428. Epub 2018 Apr 6.
Late presentation to HIV testing is overestimated when based on the consensus definition.
Sasse A, Florence E, Pharris A, De Wit S, Lacor P, Van Beckhoven D, Deblonde J, Delforge ML, Fransen K, Goffard JC, Legrand JC, Moutschen M, Piérard D, Ruelle J, Vaira D, Vandercam B, Van Ranst M, Van Wijngaerden E, Vandekerckhove L, Verhofstede C; Belgian Research AIDS & HIV Consortium (BREACH).
HIV Med. 2016 Mar;17(3):231-4. doi: 10.1111/hiv.12292. Epub 2015 Jul 28.
Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.
Van Beckhoven D, Florence E, Ruelle J, Deblonde J, Verhofstede C, Callens S, Vancutsem E, Lacor P, Demeester R, Goffard JC, Sasse A; BREACH Belgian Research on AIDS and HIV Consortium.
BMC Infect Dis. 2015 Nov 3;15:496. doi: 10.1186/s12879-015-1230-3.